Dr. Abhinav Vemula, MD

Dr. Vemula practices at Texas Digestive Disease Consultants in Flower Mound, Texas.

Dr. Vemula's NPI, 1508109281, was assigned on April 1, 2013. Dr. Vemula graduated from Boston University School Of Medicine in 2013. Dr. Vemula holds Texas license S4410.

Dr. Vemula's primary practice is Texas Digestive Disease Consultants, at 4370 Medical Arts Dr, Flower Mound, TX 75028 in Denton County. The practice phone is (972) 691-3777.

Dr. Vemula's primary practice is Texas Digestive Disease Consultants in Flower Mound, Texas. Dr. Vemula is also affiliated with Texas Health Flower Mound. The medical group on file is Texas Digestive Disease Consultants. Dmand AI also links Dr. Vemula to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vemula practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Vemula's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Vemula is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Vemula's licenses on file in 6 states: Texas, Kentucky, Tennessee, Maine, Ohio and Massachusetts.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastrointestinal bleeding, hemorrhoids and intestinal diverticulosis among the conditions Dr. Vemula treats.

CMS data shows 374 Medicare services from Dr. Vemula across 11 procedure codes in 2024, for 231 Medicare patients. Medicare paid $42,255 for them.

CMS counts 231 Medicare patients who saw Dr. Vemula in 2024. The largest group is 65 to 74, with 129 patients. 75% of them have high cholesterol, and 70% have high blood pressure. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Vemula's median patient age at 53, with 47% women.

In 2024, Dr. Vemula wrote 574 Medicare Part D claims for 237 patients. 82% of them were for generic drugs. CMS names the drug for 456 of them, across 9 drugs with 11 or more claims each, at $25,310 in total drug cost. In 2023, CMS named 357 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Vemula for performance year 2024, reported as part of a group. Dr. Vemula accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 62 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Vemula, more than 67% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Vemula, published from 2019 to 2020. Dr. Vemula's most frequent co-authors are Navin Kumar, MD, Christina A. Lebedis, MD and Alexander Merritt.

CMS Open Payments shows 178 general payments to Dr. Vemula from 25 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 98% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,031.

Dr. Vemula graduated from Boston University School Of Medicine in 2013.

Dr. Vemula is in network with 22 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.